{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:13Z","timestamp":1791925633459,"version":"4.3.4"},"reference-count":266,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Biomedicine represents one of the main study areas for dendrimers, which have proven to be valuable both in diagnostics and therapy, due to their capacity for improving solubility, absorption, bioavailability and targeted distribution. Molecular cytotoxicity constitutes a limiting characteristic, especially for cationic and higher-generation dendrimers. Antineoplastic research of dendrimers has been widely developed, and several types of poly(amidoamine) and poly(propylene imine) dendrimer complexes with doxorubicin, paclitaxel, imatinib, sunitinib, cisplatin, melphalan and methotrexate have shown an improvement in comparison with the drug molecule alone. The anti-inflammatory therapy focused on dendrimer complexes of ibuprofen, indomethacin, piroxicam, ketoprofen and diflunisal. In the context of the development of antibiotic-resistant bacterial strains, dendrimer complexes of fluoroquinolones, macrolides, beta-lactamines and aminoglycosides have shown promising effects. Regarding antiviral therapy, studies have been performed to develop dendrimer conjugates with tenofovir, maraviroc, zidovudine, oseltamivir and acyclovir, among others. Furthermore, cardiovascular therapy has strongly addressed dendrimers. Employed in imaging diagnostics, dendrimers reduce the dosage required to obtain images, thus improving the efficiency of radioisotopes. Dendrimers are macromolecular structures with multiple advantages that can suffer modifications depending on the chemical nature of the drug that has to be transported. The results obtained so far encourage the pursuit of new studies.<\/jats:p>","DOI":"10.3390\/molecules25173982","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T14:21:10Z","timestamp":1598970070000},"page":"3982","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":442,"title":["Applications and Limitations of Dendrimers in Biomedicine"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3128-2763","authenticated-orcid":false,"given":"Adriana Aurelia","family":"Chis","sequence":"first","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9913-1750","authenticated-orcid":false,"given":"Carmen","family":"Dobrea","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-8729","authenticated-orcid":false,"given":"Claudiu","family":"Morgovan","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Maria","family":"Arseniu","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-2815","authenticated-orcid":false,"given":"Luca Liviu","family":"Rus","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1540-641X","authenticated-orcid":false,"given":"Anca","family":"Butuca","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-0239","authenticated-orcid":false,"given":"Anca Maria","family":"Juncan","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Totan","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea Loredana","family":"Vonica-Tincu","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Cormos","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei Catalin","family":"Muntean","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7723-8418","authenticated-orcid":false,"given":"Maria Lucia","family":"Muresan","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3167-9864","authenticated-orcid":false,"given":"Felicia Gabriela","family":"Gligor","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4874-0430","authenticated-orcid":false,"given":"Adina","family":"Frum","sequence":"additional","affiliation":[{"name":"Preclinical Department, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 2A Lucian Blaga St., 550169 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.9734\/ACSJ\/2013\/3818","article-title":"Synthesis and a preliminary characterization of poly(propylene)imine hexadecylamine dendrimer (DAB-Am-16) modified with methyl acrylate","volume":"3","author":"Carmo","year":"2013","journal-title":"Am. Chem. Sci. J."},{"key":"ref_2","first-page":"8","article-title":"A review of synthesis, characterization and applications of functionalized dendrimers","volume":"7","author":"Augustus","year":"2017","journal-title":"Am. J. Polym. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mtchem.2019.04.004","article-title":"Poly(amidoamine)dendrimers: Covalent and supramolecular synthesis","volume":"13","author":"Lyu","year":"2019","journal-title":"Mater. Today Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jmrt.2019.10.079","article-title":"Polyamidoamine (PAMAM) dendrimers synthesis, characterization and adsorptive removal of nickel ions from aqueous solution","volume":"9","author":"Sohail","year":"2020","journal-title":"J. Mater. Res. Technol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0975-7406.130965","article-title":"Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues","volume":"6","author":"Pandita","year":"2014","journal-title":"J. Pharm. Bioallied Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1039\/c0cs00097c","article-title":"Design of biocompatible dendrimers for cancer diagnosis and therapy: Current status and future perspectives","volume":"40","author":"Cheng","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijpharm.2018.07.030","article-title":"Dendrimers: A versatile nanocarrier for drug delivery and targeting","volume":"548","author":"Sherje","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cojocaru, F.D., Botezat, D., Gardikiotis, I., Uritu, C.M., Dodi, G., Trandafir, L., Rezus, C., Rezus, E., Tamba, B.I., and Mihai, C.T. (2020). Nanomaterials designed for antiviral drug delivery transport across biological barriers. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020171"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Patel, V., Rajani, C., Paul, D., Borisa, P., Rajpoot, K., Youngren-Ortiz, S.R., and Tekade, R.K. (2020). Dendrimers as novel drug-delivery system and its applications. Drug Delivery Systems, Elsevier.","DOI":"10.1016\/B978-0-12-814487-9.00008-9"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shadrack, D., Swai, H., Munissi, J., Mubofu, E., and Nyandoro, S. (2018). Polyamidoamine dendrimers for enhanced solubility of small molecules and other desirable properties for site specific delivery: Insights from experimental and computational studies. Molecules, 23.","DOI":"10.3390\/molecules23061419"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"26363","DOI":"10.3390\/ijms161125956","article-title":"Synthesis of polyamidoamine dendrimer for encapsulating tetramethylscutellarein for potential bioactivity enhancement","volume":"16","author":"Shadrack","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/mp8002489","article-title":"Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam","volume":"6","author":"Prajapati","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.xphs.2017.10.011","article-title":"Poly(amidoamine) dendrimers as a pharmaceutical excipient. Are We There yet?","volume":"107","author":"Otto","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1409","DOI":"10.1002\/wnan.1409","article-title":"Dendrimer-based nanocarriers: A versatile platform for drug delivery","volume":"9","author":"Hsu","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bello, M., Fragoso-Vazquez, J., and Correa-Basurto, J. (2017). Theoretical studies for dendrimer-based drug delivery. Curr. Pharm. Des., 23.","DOI":"10.2174\/1381612823666170228142429"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chauhan, A.S. (2018). Dendrimers for drug delivery. Molecules, 23.","DOI":"10.3390\/molecules23040938"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2016.02.031","article-title":"Tailoring the dendrimer core for efficient gene delivery","volume":"35","author":"Hu","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: Advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Marquez-Miranda, V., Araya-Duran, I., and Gonzalez-Nilo, F.D. (2017). Multiscale molecular simulations applied to nucleic acid-dendrimer interactions studies. Curr. Pharm. Des., 23.","DOI":"10.2174\/1381612823666170306093224"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/wnan.1331","article-title":"Dendrimer-entrapped metal colloids as imaging agents","volume":"7","author":"Li","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xiao, T., Li, D., Shi, X., and Shen, M. (2020). PAMAM Dendrimer-based nanodevices for nuclear medicine applications. Macromol. Biosci., 20.","DOI":"10.1002\/mabi.201900282"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.2147\/IJN.S142385","article-title":"A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque","volume":"12","author":"Anwaier","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/1061186X.2015.1051049","article-title":"Nanocarriers for cancer-targeted drug delivery","volume":"24","author":"Kumari","year":"2016","journal-title":"J. Drug Target."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.drudis.2016.09.013","article-title":"Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery","volume":"22","author":"Sharma","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Soni, N., Tekade, M., Kesharwani, P., Bhattacharya, P., Maheshwari, R., Dua, K., Hansbro, P.M., and Tekade, R.K. (2017). Recent advances in oncological submissions of dendrimer. Curr. Pharm. Des., 23.","DOI":"10.2174\/1381612823666170329150201"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12272-018-1008-4","article-title":"Recent progress in dendrimer-based nanomedicine development","volume":"41","author":"Kim","year":"2018","journal-title":"Arch. Pharm. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acs.biomac.5b00979","article-title":"Recent advances in dendrimer research for cardiovascular diseases","volume":"16","author":"Yu","year":"2015","journal-title":"Biomacromolecules"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fruchon, S., and Poupot, R. (2018). The ABP dendrimer, a drug-candidate against inflammatory diseases that triggers the activation of interleukin-10 producing immune cells. Molecules, 23.","DOI":"10.3390\/molecules23061272"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbrc.2015.07.033","article-title":"Perspective: Dendrimer drugs for infection and inflammation","volume":"468","author":"Shaunak","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","article-title":"Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review","volume":"15","author":"Hossen","year":"2019","journal-title":"J. Adv. Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Santos, A., Veiga, F., and Figueiras, A. (2019). Dendrimers as pharmaceutical excipients: Synthesis, properties, toxicity and biomedical applications. Materials, 13.","DOI":"10.3390\/ma13010065"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1039\/c3nj01239e","article-title":"Advances in the chemistry of dendrimers","volume":"38","author":"Sowinska","year":"2014","journal-title":"New J. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Caminade, A.-M., and Majoral, J.-P. (2018). Which dendrimer to attain the desired properties? Focus on Phosphorhydrazone Dendrimers. Molecules, 23.","DOI":"10.3390\/molecules23030622"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: Synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/1385772X.2012.688328","article-title":"Polymeric micelles: Authoritative aspects for drug delivery","volume":"15","author":"Kulthe","year":"2012","journal-title":"Des. Monomers Polym."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","article-title":"Design of polymeric nanoparticles for biomedical delivery applications","volume":"41","author":"Elsabahy","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2018.06.005","article-title":"PAMAM dendrimer-cell membrane interactions","volume":"257","author":"Fox","year":"2018","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_38","first-page":"1","article-title":"Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers","volume":"4","author":"Bharali","year":"2009","journal-title":"Int. J. Nanomed."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10904-017-0768-5","article-title":"Emerging opportunities in the biomedical applications of dendrimers","volume":"28","author":"Agatemor","year":"2018","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Janaszewska, A., Lazniewska, J., Trzepi\u0144ski, P., Marcinkowska, M., and Klajnert-Maculewicz, B. (2019). Cytotoxicity of dendrimers. Biomolecules, 9.","DOI":"10.3390\/biom9080330"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1016\/S0040-4020(03)00430-7","article-title":"Structure control within poly(amidoamine) dendrimers: Size, shape and regio-chemical mimicry of globular proteins","volume":"59","author":"Tomalia","year":"2003","journal-title":"Tetrahedron"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0378-5173(02)00623-3","article-title":"The influence of surface modification on the cytotoxicity of PAMAM dendrimers","volume":"252","author":"Jevprasesphant","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-3659(99)00246-1","article-title":"Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo","volume":"65","author":"Malik","year":"2000","journal-title":"J. Control. Release"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.nano.2012.03.009","article-title":"Surface modification of PAMAM dendrimer improves its biocompatibility","volume":"8","author":"Ciolkowski","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cis.2015.01.007","article-title":"Understanding nanoparticle cellular entry: A physicochemical perspective","volume":"218","author":"Beddoes","year":"2015","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Pandurangan, A.K., Kanagesan, S., Narayanaswamy, R., Esa, N.M., and Parasuraman, P. (2016). Nanobiomaterial-based delivery of drugs in various cancer therapies: Classifying the mechanisms of action (using biochemical and molecular biomarkers). Nanobiomaterials in Cancer Therapy: Applications of Nanobiomaterials, Elsevier Inc.","DOI":"10.1016\/B978-0-323-42863-7.00011-6"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1080\/21691401.2019.1604535","article-title":"Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: An overview","volume":"47","author":"Farooq","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"119138","DOI":"10.1016\/j.ijpharm.2020.119138","article-title":"Glucose-modified carbosilane dendrimers: Interaction with model membranes and human serum albumin","volume":"579","author":"Wrobel","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_49","first-page":"28","article-title":"Dendrimers in medicine and biotechnology: New molecular tools","volume":"2","author":"Boas","year":"2006","journal-title":"RCS Publ."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ejmech.2008.04.021","article-title":"Targeting cancer cells with biotin-dendrimer conjugates","volume":"44","author":"Yang","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_51","first-page":"3361","article-title":"Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity","volume":"6","author":"Shao","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"ref_52","first-page":"1","article-title":"Bioapplications of poly(amidoamine) (PAMAM) dendrimers in nanomedicine","volume":"16","author":"Pourianazar","year":"2014","journal-title":"J. Nanopart. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.2174\/0929867311209024913","article-title":"Dendrimers and the development of new complex nanomaterials for biomedical applications","volume":"19","author":"Gardikis","year":"2012","journal-title":"Curr. Med. Chem. Curr. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1021\/bc100479t","article-title":"Synthesis of PAMAM dendrimer derivatives with enhanced buffering capacity and remarkable gene transfection efficiency","volume":"22","author":"Yu","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tiv.2009.09.014","article-title":"In vitro mammalian cytotoxicological study of PAMAM dendrimers\u2014Towards quantitative structure activity relationships","volume":"24","author":"Mukherjee","year":"2010","journal-title":"Toxicol. Vitr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.taap.2010.08.016","article-title":"Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells","volume":"248","author":"Mukherjee","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/0008-5472.CAN-12-2704","article-title":"Tissue damage-associated \u201cdanger signals\u201d influence T-cell responses that promote the progression of preneoplasia to cancer","volume":"73","author":"He","year":"2013","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","article-title":"Mechanism of action of conventional and targeted anticancer therapies: Reinstating immunosurveillance","volume":"39","author":"Zitvogel","year":"2013","journal-title":"Immunity"},{"key":"ref_60","first-page":"311","article-title":"Targeted therapies: A new generation of cancer treatments","volume":"77","author":"Gerber","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrclinonc.2012.99","article-title":"Reducing the toxicity of cancer therapy: Recognizing needs, taking action","volume":"9","author":"Cleeland","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Morikawa, A. (2016). Comparison of properties among dendritic and hyperbranched poly(ether ether ketone)s and linear poly(ether ketone)s. Molecules, 21.","DOI":"10.3390\/molecules21020219"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1590\/0001-3765201820170387","article-title":"Perspectives of dendrimer-based nanoparticles in cancer therapy","volume":"90","author":"Castro","year":"2018","journal-title":"An. Acad. Bras. Cienc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1021\/cr900174j","article-title":"Dendrimers as carriers for delivery of chemotherapeutic agents","volume":"109","author":"Medina","year":"2009","journal-title":"Chem. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3390\/nano5041690","article-title":"Multifunctional nanomaterials and their applications in drug delivery and cancer therapy","volume":"5","author":"Srinivasan","year":"2015","journal-title":"Nanomaterials"},{"key":"ref_66","first-page":"19","article-title":"Applications of dendrimers in drug delivery agents, diagnosis, therapy, and detection","volume":"2014","author":"Bustos","year":"2014","journal-title":"J. Nanomater."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fphar.2017.00261","article-title":"Impact of dendrimers on solubility of hydrophobic drug molecules","volume":"8","author":"Choudhary","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3109\/21691401.2015.1129625","article-title":"Dendrimers in anticancer drug delivery: Mechanism of interaction of drug and dendrimers","volume":"44","author":"Singh","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1039\/C4TB00171K","article-title":"Dendrimers for drug delivery","volume":"2","author":"Caminade","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.colsurfb.2016.04.035","article-title":"Targeted conjugation of breast anticancer drug tamoxifen and its metabolites with synthetic polymers","volume":"145","author":"Sanyakamdhorn","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jconrel.2015.11.004","article-title":"Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer","volume":"220","author":"Liu","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1021\/mp500608s","article-title":"Poly(amidoamine) dendrimer-methotrexate conjugates: The mechanism of interaction with folate binding protein","volume":"11","author":"Rattan","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"58600","DOI":"10.1039\/C5RA07987J","article-title":"Click synthesis of a polyamidoamine dendrimer-based camptothecin prodrug","volume":"5","author":"Zolotarskaya","year":"2015","journal-title":"RSC Adv."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acs.molpharmaceut.5b00876","article-title":"Poly(amidoamine) dendrimer-doxorubicin conjugates: In vitro characteristics and pseudosolution formulation in pressurized metered-dose inhalers","volume":"13","author":"Zhong","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1021\/bc060228x","article-title":"Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: The effect of substitutes at the hydrazone linkage on the pH stability of PEG-PE conjugates","volume":"18","author":"Kale","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"ref_76","unstructured":"Nieznanski, K., Nieznanska, H., Surewicz, W.K., Surewicz, K., and Bandyszewska, M. (2019). US20190092837A1-Prion Protein-Dendrimer Conjugates for Use in Treatment of Alzheimer Disease. (Application No. 16\/300,214), U.S. Patents."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejpb.2011.03.025","article-title":"RGD-modified PEG-PAMAM-DOX conjugates: In vitro and in vivo studies for glioma","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1021\/mp500128k","article-title":"Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells","volume":"11","author":"Satsangi","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1600457","DOI":"10.1002\/mabi.201600457","article-title":"Omega-3 fatty acid grafted PAMAM-paclitaxel conjugate exhibits enhanced anticancer activity in upper gastrointestinal cancer cells","volume":"17","author":"Dichwalkar","year":"2017","journal-title":"Macromol. Biosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"219","DOI":"10.18388\/abp.2017_2331","article-title":"Dendrimer-paclitaxel complexes for efficient treatment in ovarian cancer: Study on OVCAR-3 and HEK293T cells","volume":"65","author":"Yao","year":"2018","journal-title":"Acta Biochim. Pol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.drudis.2014.12.012","article-title":"Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery","volume":"20","author":"Kesharwani","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jconrel.2004.07.027","article-title":"Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine","volume":"99","author":"Choi","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1000164","DOI":"10.4172\/2157-7439.1000164","article-title":"Paclitaxel nano-delivery systems: A comprehensive review","volume":"4","author":"Ma","year":"2013","journal-title":"J. Nanomed. Nanotechnol."},{"key":"ref_84","first-page":"897","article-title":"Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: Role of SMVT","volume":"31","author":"Yellepeddi","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_85","unstructured":"Tripodo, G., Mandracchia, D., Collina, S., Rui, M., and Rossi, D. (2014). Medicinal chemistry new perspectives in cancer therapy: The biotin-antitumor molecule conjugates. Med. Chem., 1."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","article-title":"Cancer active targeting by nanoparticles: A comprehensive review of literature","volume":"141","author":"Bazak","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1038\/srep23179","article-title":"Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer","volume":"6","author":"Kulhari","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clbc.2013.04.001","article-title":"Current status of anti-human epidermal growth factor receptor 2 therapies: Predicting and overcoming Herceptin resistance","volume":"13","author":"Chung","year":"2013","journal-title":"Clin. Breast Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"102043","DOI":"10.1016\/j.nano.2019.102043","article-title":"An innovative in situ method of creating hybrid dendrimer nano-assembly: An efficient next generation dendritic platform for drug delivery","volume":"21","author":"Singh","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.ejmech.2007.12.021","article-title":"Dendrimers as versatile platform in drug delivery applications","volume":"43","author":"Cheng","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nano.2008.06.002","article-title":"Emerging nanopharmaceuticals","volume":"4","author":"Bawarski","year":"2008","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10867-012-9277-5","article-title":"Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy","volume":"38","author":"Markowicz","year":"2012","journal-title":"J. Biol. Phys."},{"key":"ref_93","first-page":"1","article-title":"PEGylated nanoarchitechture mediated solubility enhancement of tyrosine-kinase inhibitor","volume":"2","author":"Karthikeyan","year":"2015","journal-title":"Inventi Rapid: Novel Excipients"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1039\/C6TB00710D","article-title":"Partially PEGylated dendrimer-entrapped gold nanoparticles: A promising nanoplatform for highly efficient DNA and siRNA delivery","volume":"4","author":"Hou","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","article-title":"PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy","volume":"12","author":"Dehghan","year":"2018","journal-title":"Appl. Mater. Today"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejpb.2015.08.001","article-title":"Tumor targeting using polyamidoamine dendrimer-cisplatin nanoparticles functionalized with diglycolamic acid and herceptin","volume":"96","author":"Kesavan","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2013.01.035","article-title":"Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer","volume":"169","author":"Mi","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_98","unstructured":"Broome, A.-M. (2018). Advances in Cancer Research: Cancer Nanotechnology, Elsevier Academic Press. [1st ed.]."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Chitkara, D., Ampama, M., and Mahato, R.I. (2019). Molecular Medicines for Cancer: Concepts and Applications of Nanotechn, CRC Press.","DOI":"10.1201\/9781315269214"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1359-6446(01)01757-3","article-title":"Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications","volume":"6","author":"Esfand","year":"2001","journal-title":"Drug Discov. Today"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: Progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fbioe.2020.00127","article-title":"Nanoscale self-assembly for therapeutic delivery","volume":"8","author":"Yadav","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_103","unstructured":"Le, P.N., Nguyen, D.H., Nguyen, C.K., and Tran, N.Q. (2019). Dendrimers for controlled release drug delivery. Dendrimers for Drug Delivery, Apple Academic Press."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1007\/s11095-011-0530-6","article-title":"Development of novel peptides for mitochondrial drug delivery: Amino acids featuring delocalized lipophilic cations","volume":"28","author":"Kelley","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.addr.2005.09.014","article-title":"Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex","volume":"57","author":"Patri","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1166\/jnn.2015.9808","article-title":"Improved method for preparing cisplatin-dendrimer nanocomplex and its behavior against NCI-H460 lung cancer cell","volume":"15","author":"Nguyen","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Vu, M.T., Bach, L.G., Nguyen, D.C., Ho, M.N., Nguyen, N.H., Tran, N.Q., Nguyen, D.H., Nguyen, C.K., and Hoang Thi, T.T. (2019). Modified carboxyl-terminated PAMAM dendrimers as great cytocompatible nano-based drug delivery system. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20082016"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1158\/1535-7163.MCT-14-0556","article-title":"Multifunctional polymeric micelles co-loaded with anti-survivin siRNA and paclitaxel overcome drug resistance in an animal model of ovarian cancer","volume":"14","author":"Salzano","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1002\/smll.201600925","article-title":"Mixed nanosized polymeric micelles as promoter of doxorubicin and miRNA-34a co-delivery triggered by dual stimuli in tumor tissue","volume":"12","author":"Salzano","year":"2016","journal-title":"Small"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1073\/pnas.1004604107","article-title":"Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance","volume":"107","author":"Garbuzenko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2014.02.021","article-title":"How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo","volume":"181","author":"Shcharbin","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/bc00023a012","article-title":"Polyamidoamine cascade polymers mediate efficient transfection of cells in culture","volume":"4","author":"Haensler","year":"1993","journal-title":"Bioconjug. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1002\/adfm.201403921","article-title":"Structure-invertible nanoparticles for triggered co-delivery of nucleic acids and hydrophobic drugs for combination cancer therapy","volume":"25","author":"Wang","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1602697","DOI":"10.1002\/smll.201602697","article-title":"Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide modified dendrimer for the treatment of pancreatic cancer","volume":"13","author":"Li","year":"2017","journal-title":"Small"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Caminade, A.-M. (2020). Phosphorus dendrimers as nanotools against cancers. Molecules, 25.","DOI":"10.3390\/molecules25153333"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"109072","DOI":"10.1016\/j.biopha.2019.109072","article-title":"A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer","volume":"117","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.msec.2016.09.035","article-title":"A polyamidoamne dendrimer functionalized graphene oxide for DOX and MMP-9 shRNA plasmid co-delivery","volume":"70","author":"Gu","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/joim.12280","article-title":"Emerging concepts in dendrimer-based nanomedicine: From design principles to clinical applications","volume":"276","author":"Kannan","year":"2014","journal-title":"J. Intern. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0079-6700(00)00011-3","article-title":"Functional dendrimers, hyperbranched and star polymers","volume":"25","author":"Inoue","year":"2000","journal-title":"Prog. Polym. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10611860600635665","article-title":"Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes)","volume":"14","author":"Tack","year":"2006","journal-title":"J. Drug Target."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s11095-014-1549-2","article-title":"Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations","volume":"32","author":"Kesharwani","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nano.2014.09.006","article-title":"The development, characterization and in vivo anti-ovarian cancer activity of poly(propylene imine) (PPI)-antibody conjugates containing encapsulated paclitaxel","volume":"11","author":"Jain","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_123","unstructured":"Gorzkiewicz, M., and Klajnert-Maculewicz, B. (2019). Dendrimers as Nanocarriers for Anticancer Drugs, Apple Academic Press."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/10611860802473154","article-title":"Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy","volume":"16","author":"Tekade","year":"2008","journal-title":"J. Drug Target."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1166\/jbn.2015.2077","article-title":"Folate receptor-targeted dendrimer-methotrexate conjugate for inflammatory arthritis","volume":"11","author":"Qi","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1039\/B901839P","article-title":"Biomedical applications of dendrimers: A tutorial","volume":"40","author":"Mintzer","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/nn305860k","article-title":"Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo","volume":"7","author":"Wang","year":"2013","journal-title":"ACS Nano"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Wu, J., Huang, W., and He, Z. (2013). Dendrimers as carriers for siRNA delivery and gene silencing: A review. Sci. World J., 2013.","DOI":"10.1155\/2013\/630654"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1021\/acs.molpharmaceut.5b00946","article-title":"Size and surface charge of engineered poly(amidoamine) dendrimers modulate tumor accumulation and penetration: A model study using multicellular tumor spheroids","volume":"13","author":"Bugno","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1002\/anie.201500683","article-title":"Bioinspired therapeutic dendrimers as efficient peptide drugs based on supramolecular interactions for tumor inhibition","volume":"54","author":"Zhang","year":"2015","journal-title":"Angew. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1039\/C6BM00090H","article-title":"Interactions of dendrimers with biological drug targets: Reality or mystery-a gap in drug delivery and development research","volume":"4","author":"Ahmed","year":"2016","journal-title":"Biomater. Sci."},{"key":"ref_132","unstructured":"European Medicines Agency (2007). Guideline on Excipients in the Dossier for Application for Marketing Authorisation of a Medicinal Product, EMA."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijpharm.2015.03.034","article-title":"Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action","volume":"485","author":"Dzmitruk","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ejoc.201101376","article-title":"Molecular and macromolecular engineering with viologens as building blocks: Rational design of phosphorus-viologen dendritic structures","volume":"2012","author":"Katir","year":"2012","journal-title":"Eur. J. Org. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1021\/mp200549c","article-title":"Biological properties of new viologen-phosphorus dendrimers","volume":"9","author":"Ciepluch","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.3390\/molecules181012222","article-title":"Promising low-toxicity of viologen-phosphorus dendrimers against embryonic mouse hippocampal cells","volume":"18","author":"Lazniewska","year":"2013","journal-title":"Molecules"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"58038","DOI":"10.18632\/oncotarget.10846","article-title":"Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_138","first-page":"6854","article-title":"Utilizing ethacrynic acid and ciclopirox olamine in liver cancer","volume":"16","author":"Weiher","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"113920","DOI":"10.1016\/j.bcp.2020.113920","article-title":"Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells","volume":"175","author":"Lee","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1039\/C4NR05983B","article-title":"Investigations on dendrimer space reveal solid and liquid tumor growth-inhibition by original phosphorus-based dendrimers and the corresponding monomers and dendrons with ethacrynic acid motifs","volume":"7","author":"Mignani","year":"2015","journal-title":"Nanoscale"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejmech.2016.05.063","article-title":"A novel class of ethacrynic acid derivatives as promising drug-like potent generation of anticancer agents with established mechanism of action","volume":"122","author":"Mignani","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ica.2017.04.044","article-title":"Dual properties of water-soluble Ru-PTA complexes of dendrimers: Catalysis and interaction with DNA","volume":"470","author":"Servin","year":"2018","journal-title":"Inorg. Chim. Acta"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/mp4000184","article-title":"Original multivalent copper(II)-conjugated phosphorus dendrimers and corresponding mononuclear copper(II) complexes with antitumoral activities","volume":"10","author":"Mignani","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/acs.molpharmaceut.7b00771","article-title":"Original multivalent Gold(III) and dual Gold(III)-Copper(II) conjugated phosphorus dendrimers as potent antitumoral and antimicrobial agents","volume":"14","author":"Mignani","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_145","first-page":"383","article-title":"Biomedical Applications of photo- and sono-activated rose bengal: A review","volume":"37","author":"Vanerio","year":"2019","journal-title":"Photobiomodul. Photomed. Laser Surg."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1021\/acs.molpharmaceut.7b00108","article-title":"Cationic phosphorus dendrimer enhances photodynamic activity of rose bengal against basal cell carcinoma cell lines","volume":"14","author":"Dabrzalska","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","volume":"39","author":"Kesharwani","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1023\/A:1021410028371","article-title":"Poor aqueous solubility\u2014An industry wide problem in drug discovery","volume":"19","author":"Lipinski","year":"2002","journal-title":"Am. Pharm. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","article-title":"Improving drug solubility for oral delivery using solid dispersions","volume":"50","author":"Leuner","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/00319100500493063","article-title":"Solubilization of non-steroidal anti-inflammatory drugs in the presence of tween series surfactants","volume":"44","author":"Yiyun","year":"2006","journal-title":"Phys. Chem. Liq."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ejmech.2005.06.010","article-title":"Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers","volume":"40","author":"Yiyun","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s10953-011-9709-z","article-title":"Solubility of nonsteroidal anti-inflammatory drugs (NSAIDs) in aqueous solutions of non-ionic surfactants","volume":"40","author":"Ullah","year":"2011","journal-title":"J. Solut. Chem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/bc010102u","article-title":"Polyester dendritic systems for drug delivery applications: Design, synthesis, and characterization","volume":"13","author":"Ihre","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Markowicz-Piasecka, M., and Mikiciuk-Olasik, E. (2016). Nanobiomaterials in Drug Delivery, Elsevier. [1st ed.].","DOI":"10.1016\/B978-0-323-42866-8.00002-2"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1016\/S0040-4020(03)00437-X","article-title":"Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives","volume":"59","author":"Beezer","year":"2003","journal-title":"Tetrahedron"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00011-016-0959-5","article-title":"In vivo proinflammatory activity of generations 0\u20133 (G0\u2013G3) polyamidoamine (PAMAM) nanoparticles","volume":"65","author":"Durocher","year":"2016","journal-title":"Inflamm. Res."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Scorciapino, M., Serra, I., Manzo, G., and Rinaldi, A. (2017). Antimicrobial dendrimeric peptides: Structure, activity and new therapeutic applications. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030542"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/03639045.2017.1391838","article-title":"Formulation and delivery strategies of ibuprofen: Challenges and opportunities","volume":"44","author":"Irvine","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0090-6980(02)00026-6","article-title":"The structures of prostaglandin endoperoxide H synthases-1 and -2","volume":"68\u201369","author":"Garavito","year":"2002","journal-title":"Prostaglandins Lipid Mediat."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2332\/allergolint.54.209","article-title":"Recent advances in nonsteroidal anti-inflammatory drugs","volume":"54","author":"Kawai","year":"2005","journal-title":"Allergol. Int."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1163\/156856005774415565","article-title":"The use of NSAIDs in rheumatic disorders 2005: A global perspective","volume":"13","author":"Kean","year":"2005","journal-title":"Inflammopharmacology"},{"key":"ref_162","first-page":"412","article-title":"Changes in the gene expression profile of gastric cancer cells in response to ibuprofen: A gene pathway analysis","volume":"11","author":"Bonelli","year":"2011","journal-title":"Pharm. J."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2009.10.017","article-title":"Drug release characteristics of PAMAM dendrimer-drug conjugates with different linkers","volume":"384","author":"Kurtoglu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.biomaterials.2005.06.007","article-title":"Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload","volume":"27","author":"Kolhe","year":"2006","journal-title":"Biomaterials"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S1984-82502013000700006","article-title":"Dendrimers as anti-inflammatory agents","volume":"49","author":"Avti","year":"2013","journal-title":"Braz. J. Pharm. Sci."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-5173(03)00225-4","article-title":"Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers","volume":"259","author":"Kolhe","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2013.04.062","article-title":"Solubility enhancement of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) using polypolypropylene oxide core PAMAM dendrimers","volume":"451","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_168","unstructured":"Ohshima, H., and Makino, K. (2014). Colloid and Interface Science in Pharmaceutical Research and Development, Elsevier Inc."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nhtm.2017.08.001","article-title":"Pros, cons and future of antibiotics","volume":"4","author":"Weledji","year":"2017","journal-title":"New Horiz. Transl. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"bar054","DOI":"10.1093\/database\/bar054","article-title":"RAC: Repository of Antibiotic resistance Cassettes","volume":"2011","author":"Tsafnat","year":"2011","journal-title":"Database"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMp1215093","article-title":"The future of antibiotics and resistance","volume":"368","author":"Spellberg","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fmicb.2013.00255","article-title":"The multiple roles of antibiotics and antibiotic resistance in nature","volume":"4","author":"Walsh","year":"2013","journal-title":"Front. Microbiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/jac\/dkx513","article-title":"Automated annotation of mobile antibiotic resistance in Gram-negative bacteria: The Multiple Antibiotic Resistance Annotator (MARA) and database","volume":"73","author":"Partridge","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2165\/00044011-199612020-00003","article-title":"Comparative study of teicoplanin vs vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia","volume":"12","author":"Liu","year":"1996","journal-title":"Clin. Drug Investig."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrmicro732","article-title":"The damage-response framework of microbial pathogenesis","volume":"1","author":"Casadevall","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Petrosillo, N. (2020). Infections: The emergency of the new millennium. Nuclear Medicine in Infectious Diseases, Springer.","DOI":"10.1007\/978-3-030-25494-0_1"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Srividya, N., Ghoora, M.D., and Padmanabh, P.R. (2017). Antimicrobial nanotechnology: Research implications and prospects in food safety. Food Preservation, Elsevier.","DOI":"10.1016\/B978-0-12-804303-5.00004-3"},{"key":"ref_178","unstructured":"Karthikeyan, R., Koushik, O.S., and Kumar, P.V. (2019). Dendrimeric architecture for effective antimicrobial therapy in: Dendrimers for drug delivery. Dendrimers for Controlled Release Drug Delivery, Apple Academic Press Inc."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Authimoolam, S., and Dziubla, T. (2016). Biopolymeric mucin and synthetic polymer analogs: Their structure, function and role in biomedical applications. Polymers, 8.","DOI":"10.3390\/polym8030071"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ejmech.2006.12.035","article-title":"Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: An in vitro study","volume":"42","author":"Cheng","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdermsci.2005.01.002","article-title":"Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes","volume":"38","author":"Kuwahara","year":"2005","journal-title":"J. Dermatol. Sci."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Svenningsen, S.W., Frederiksen, R.F., Counil, C., Ficker, M., Leisner, J.J., and Christensen, J.B. (2020). Synthesis and Antimicrobial Properties of a Ciprofloxacin and PAMAM-dendrimer Conjugate. Molecules, 25.","DOI":"10.3390\/molecules25061389"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Wro\u0144ska, N., Majoral, J.P., Appelhans, D., Bryszewska, M., and Lisowska, K. (2019). Synergistic effects of anionic\/cationic dendrimers and levofloxacin on antibacterial activities. Molecules, 24.","DOI":"10.3390\/molecules24162894"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: No ESKAPE! An update from the infectious diseases society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Kamaruzzaman, N.F., Tan, L.P., Hamdan, R.H., Choong, S.S., Wong, W.K., Gibson, A.J., Chivu, A., and Pina, M.D.F. (2019). Antimicrobial polymers: The potential replacement of existing antibiotics?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112747"},{"key":"ref_187","unstructured":"Lindmeier, C. (2018). High Levels of Antibiotic Resistance Found Worldwide, New Data Shows, WHO."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/2211738507666190320160802","article-title":"Functional nanomaterials and their potential applications in antibacterial therapy","volume":"7","author":"Hong","year":"2019","journal-title":"Pharm. Nanotechnol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.joen.2016.05.021","article-title":"Antibacterial nanoparticles in endodontics: A review","volume":"42","author":"Shrestha","year":"2016","journal-title":"J. Endod."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2217\/nnm-2017-0052","article-title":"Development of antifungal therapies using nanomaterials","volume":"12","author":"Niemirowicz","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2217\/nnm-2017-0391","article-title":"Antibiofilm effect of drug-free and cationic poly(D,L-lactide-co-glycolide) nanoparticles via nano-bacteria interactions","volume":"13","author":"Zhu","year":"2018","journal-title":"Nanomedicine"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.3390\/molecules18078607","article-title":"The effect of PAMAM dendrimers on the antibacterial activity of antibiotics with different water solubility","volume":"18","author":"Winnicka","year":"2013","journal-title":"Molecules"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1089\/wound.2019.1113","article-title":"Are antimicrobial peptide dendrimers an escape from ESKAPE?","volume":"9","author":"Kawano","year":"2020","journal-title":"Adv. Wound Care"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Gallego, S., Franci, G., Falanga, A., G\u00f3mez, R., Folliero, V., Galdiero, S., de la Mata, F., and Galdiero, M. (2017). Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials. Molecules, 22.","DOI":"10.3390\/molecules22101581"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/wnan.79","article-title":"Understanding specific and nonspecific toxicities: A requirement for the development of dendrimer-based pharmaceuticals","volume":"2","author":"McNerny","year":"2010","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1039\/b904746h","article-title":"Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers","volume":"5","author":"Lopez","year":"2009","journal-title":"Mol. Biosyst."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1039\/b809569h","article-title":"Amine and ammonium functionalization of chloromethylsilane-ended dendrimers. Antimicrobial activity studies","volume":"6","author":"Ortega","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejps.2018.07.051","article-title":"Synthesis of the erythromycin-conjugated nanodendrimer and its antibacterial activity","volume":"123","author":"Fallah","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1208\/s12248-012-9416-8","article-title":"Amino-terminated generation 2 poly(amidoamine) dendrimer as a potential broad-spectrum, nonresistance-inducing antibacterial agent","volume":"15","author":"Xue","year":"2013","journal-title":"AAPS J."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1021\/bm0701088","article-title":"Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups","volume":"8","author":"Calabretta","year":"2007","journal-title":"Biomacromolecules"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"20277","DOI":"10.3390\/ijms160920277","article-title":"The effect of cationic polyamidoamine dendrimers on physicochemical characteristics of hydrogels with erythromycin","volume":"16","author":"Winnicka","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/485439a","article-title":"Antibiotics: Recover the lost art of drug discovery","volume":"485","author":"Lewis","year":"2012","journal-title":"Nature"},{"key":"ref_203","unstructured":"Brownlie, J., Peckham, C., Waage, J., Woolhouse, M., Lyall, C., Meagher, L., Tait, J., Baylis, M., and Nicoll, A. (2006). Infectious Diseases: Preparing for the Future\u2014Future Threats, Office of Science and Innovation."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Mhlwatika, Z., and Aderibigbe, B. (2018). Application of dendrimers for the treatment of infectious diseases. Molecules, 23.","DOI":"10.3390\/molecules23092205"},{"key":"ref_205","first-page":"1281","article-title":"Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-I","volume":"11","author":"Maly","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"ref_206","first-page":"1","article-title":"Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment","volume":"17","author":"Pavicic","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"12733","DOI":"10.1039\/c2dt31099f","article-title":"Synthesis, structure and molecular modelling of anionic carbosilane dendrimers","volume":"41","author":"Rasines","year":"2012","journal-title":"Dalton Trans."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/pola.27090","article-title":"Synthesis of anionic carbosilane dendrimers via \u201cclick chemistry\u201d and their antiviral properties against HIV","volume":"52","author":"Pion","year":"2014","journal-title":"J. Polym. Sci. Part A Polym. Chem."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.nano.2015.03.008","article-title":"Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment\/therapy","volume":"11","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2217\/nnm.14.79","article-title":"Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission","volume":"10","year":"2015","journal-title":"Nanomedicine"},{"key":"ref_211","first-page":"1","article-title":"Antiviral potential of 3\u2032-sialyllactose- and 6\u2032-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses","volume":"10","author":"Maier","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Sandoval-Ya\u00f1ez, C., and Rodriguez, C.C. (2020). Dendrimers: Amazing platforms for bioactive molecule delivery systems. Materials, 13.","DOI":"10.3390\/ma13030570"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1016\/j.biomaterials.2013.02.008","article-title":"Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejps.2016.09.005","article-title":"Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide","volume":"96","author":"Singh","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10837450.2016.1219372","article-title":"The effect of PAMAM dendrimer concentration, generation size and surface functional group on the aqueous solubility of candesartan cilexetil","volume":"22","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.12.002","article-title":"Performance evaluation of PAMAM dendrimer based simvastatin formulations","volume":"405","author":"Kulhari","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-8977-2-1","article-title":"Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy","volume":"2","author":"Maynard","year":"2005","journal-title":"Part. Fibre Toxicol."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Mostafavi, E., Soltantabar, P., and Webster, T.J. (2019). Nanotechnology and picotechnology. Biomaterials in Translational Medicine, Elsevier Inc.","DOI":"10.1016\/B978-0-12-813477-1.00009-8"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Pillai, G. (2019). Nanotechnology toward treating cancer. Applications of Targeted Nano Drugs and Delivery Systems, Elsevier.","DOI":"10.1016\/B978-0-12-814029-1.00009-0"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"11454","DOI":"10.1073\/pnas.1812938115","article-title":"Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors","volume":"115","author":"Garriguea","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"216rv4","DOI":"10.1126\/scitranslmed.3005872","article-title":"Cancer nanomedicine: From drug delivery to imaging","volume":"5","author":"Chow","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nmat3877","article-title":"A targeted approach to cancer imaging and therapy","volume":"13","author":"Li","year":"2014","journal-title":"Nat. Mater."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1126\/science.1185547","article-title":"Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures","volume":"328","author":"Percec","year":"2010","journal-title":"Science"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1073\/pnas.1418494112","article-title":"Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance","volume":"112","author":"Wei","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1021\/acs.chemrev.7b00097","article-title":"Mimicking complex biological membranes and their programmable glycan ligands with dendrimersomes and glycodendrimersomes","volume":"117","author":"Sherman","year":"2017","journal-title":"Chem. Rev."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/cr3003104","article-title":"Radiometals for combined imaging and therapy","volume":"113","author":"Cutler","year":"2013","journal-title":"Chem. Rev."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Markowicz-Piasecka, M., Sikora, J., Szymanski, P., Kozak, O., Studniarek, M., and Mikiciuk-Olasik, E. (2015). PAMAM dendrimers as potential carriers of gadolinium complexes of iminodiacetic acid derivatives for magnetic resonance imaging. J. Nanomater.","DOI":"10.1155\/2015\/394827"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1142\/S1793292011002871","article-title":"Nanotechnology in pharmaceutical and biomedical applications: Dendrimers","volume":"6","author":"Markowicz","year":"2011","journal-title":"Nano"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1039\/b510982p","article-title":"Strategies for increasing the sensitivity of gadolinium based MRI contrast agents","volume":"35","author":"Caravan","year":"2006","journal-title":"Chem. Soc. Rev."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnmrs.2006.06.001","article-title":"The application of NMR in tumor angiogenesis research","volume":"49","author":"Dadiani","year":"2006","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/wnan.1250","article-title":"Dendrimers as high relaxivity MR contrast agents","volume":"6","author":"Longmire","year":"2014","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"e1496","DOI":"10.1002\/wnan.1496","article-title":"Two decades of dendrimers as versatile MRI agents: A tale with and without metals","volume":"10","author":"McMahon","year":"2018","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/acs.bioconjchem.5b00031","article-title":"Dendrimers in medicine: Therapeutic concepts and pharmaceutical challenges","volume":"26","author":"Wu","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1148\/radiol.2019190452","article-title":"Opportunities in interventional and diagnostic imaging by using high-performance low-field-strength MRI","volume":"293","author":"Ramasawmy","year":"2019","journal-title":"Radiology"},{"key":"ref_236","unstructured":"Chauhan, A., and Kulhari, H. (2020). Chapter 13. Dendrimers for diagnostic applications. Pharmaceutical Applications of Dendrimers, Elsevier Inc."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1515\/bmc-2015-0012","article-title":"Dendrimers for theranostic applications","volume":"6","author":"Sk","year":"2015","journal-title":"Biomol. Concepts"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/mrm.10312","article-title":"Magnetic resonance relaxivity of dendrimer-linked nitroxides","volume":"48","author":"Winalski","year":"2002","journal-title":"Magn. Reson. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1021\/jp0350666","article-title":"Relaxivity studies on dinitroxide and polynitroxyl functionalized dendrimers: Effect of electron exchange and structure on paramagnetic relaxation enhancement","volume":"107","author":"Maliakal","year":"2003","journal-title":"J. Phys. Chem. A"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Zhang, S., Lloveras, V., Pulido, D., Liko, F., Pinto, L.F., Albericio, F., Royo, M., and Vidal-Gancedo, J. (2020). Radical Dendrimers based on biocompatible oligoethylene glycol dendrimers as contrast agents for MRI. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080772"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mrc.1151","article-title":"Functionalization of PAMAM dendrimers with nitronyl nitroxide radicals as models for the outer-sphere relaxation in dentritic potential MRI contrast agents","volume":"41","author":"Francese","year":"2003","journal-title":"Magn. Reson. Chem."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"15724","DOI":"10.1021\/ja3079829","article-title":"Organic radical contrast agents for magnetic resonance imaging","volume":"134","author":"Rajca","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/acsabm.9b00855","article-title":"Fully water-soluble polyphosphorhydrazone-based radical dendrimers functionalized with Tyr-PROXYL radicals as metal-free MRI T1 contrast agents","volume":"3","author":"Pinto","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/cn400182z","article-title":"Dendrimer advances for the central nervous system delivery of therapeutics","volume":"5","author":"Xu","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s11095-007-9415-0","article-title":"Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells","volume":"24","author":"Kitchens","year":"2007","journal-title":"Pharm. Res."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00726-010-0707-z","article-title":"Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications","volume":"40","author":"Sebestik","year":"2011","journal-title":"Amino Acids"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1021\/ma0106346","article-title":"Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery","volume":"35","author":"Luo","year":"2002","journal-title":"Macromolecules"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1021\/bc800125u","article-title":"Folate and folate-PEG-PAMAM dendrimers: Synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice","volume":"19","author":"Singh","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1007\/s11164-018-3280-9","article-title":"Design of peptide\u2013dendrimer conjugates with tumor homing and antitumor effects","volume":"44","author":"Kojima","year":"2018","journal-title":"Res. Chem. Intermed."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2174\/138945011796818135","article-title":"Evaluation of dendrimer safety and efficacy through cell line studies","volume":"12","author":"Kesharwani","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2005.01.026","article-title":"Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting","volume":"295","author":"Bhadra","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.biomaterials.2007.04.004","article-title":"Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate","volume":"28","author":"Agrawal","year":"2007","journal-title":"Biomaterials"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1211\/jpp.58.11.0010","article-title":"Investigations on the toxicological profile of functionalized fifth-generation poly(propylene imine) dendrimer","volume":"58","author":"Agashe","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/mp200463e","article-title":"Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro","volume":"9","author":"Dobrovolskaia","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Enciso, A., Neun, B., Rodriguez, J., Ranjan, A., Dobrovolskaia, M., and Simanek, E. (2016). Nanoparticle effects on human platelets in vitro: A comparison between PAMAM and triazine dendrimers. Molecules, 21.","DOI":"10.3390\/molecules21040428"},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Spyropoulos-Antonakakis, N., Sarantopoulou, E., Trohopoulos, P.N., Stefi, A.L., Kollia, Z., Gavriil, V.E., Bourkoula, A., Petrou, P.S., Kakabakos, S., and Semashko, V.V. (2015). Selective aggregation of PAMAM dendrimer nanocarriers and PAMAM\/ZnPc nanodrugs on human atheromatous carotid tissues: A photodynamic therapy for atherosclerosis. Nanoscale Res. Lett., 10.","DOI":"10.1186\/s11671-015-0904-5"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.taap.2010.04.014","article-title":"Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells","volume":"246","author":"Naha","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","article-title":"Dendrimer biocompatibility and toxicity","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Vidal, F., V\u00e1squez, P., Cayum\u00e1n, F., D\u00edaz, C., Fuentealba, J., Aguayo, L., Y\u00e9venes, G., Alderete, J., and Guzm\u00e1n, L. (2017). Prevention of synaptic alterations and neurotoxic effects of PAMAM dendrimers by surface functionalization. Nanomaterials, 8.","DOI":"10.3390\/nano8010007"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.7150\/thno.13181","article-title":"Interplay of oxidative stress and autophagy in PAMAM dendrimers-induced neuronal cell death","volume":"5","author":"Li","year":"2015","journal-title":"Theranostics"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.3390\/molecules180911537","article-title":"Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier","volume":"18","author":"Hemmer","year":"2013","journal-title":"Molecules"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/toxsci\/kfw068","article-title":"Effects of polyamidoamine dendrimers on a 3-D neurosphere system using human neural progenitor cells","volume":"152","author":"Zeng","year":"2016","journal-title":"Toxicol. Sci."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.toxlet.2014.04.020","article-title":"Effects of PAMAM dendrimers in the mouse brain after a single intranasal instillation","volume":"228","author":"Sone","year":"2014","journal-title":"Toxicol. Lett."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1517\/17425240903061251","article-title":"Surface modified poly(amido) amine dendrimers as diverse nanomolecules for biomedical applications","volume":"6","author":"Yellepeddi","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1021\/bc0603889","article-title":"Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability","volume":"18","author":"Kolhatkar","year":"2007","journal-title":"Bioconjug. +Chem."},{"key":"ref_266","unstructured":"Chauhan, A., and Kulhari, H. (2020). Pharmaceutical Applications of Dendrimers, Elsevier. [1st ed.]."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/17\/3982\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:05:32Z","timestamp":1760177132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/17\/3982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":266,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["molecules25173982"],"URL":"https:\/\/doi.org\/10.3390\/molecules25173982","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}